Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma

NCT03994705 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Phase 1 enrollment completed. Further clinical development terminated.

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: Descartes-11
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Cartesian Therapeutics

Collaborators

[object Object]